Mark Sistoso, | |
4301 Wilson St, Fort Sill, OK 73503-4472 | |
(719) 205-0017 | |
Not Available |
Full Name | Mark Sistoso |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 4301 Wilson St, Fort Sill, Oklahoma |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1720407752 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367500000X | Nurse Anesthetist, Certified Registered | C003258 (Arkansas) | Secondary |
367500000X | Nurse Anesthetist, Certified Registered | AP60451158 (Washington) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mark Sistoso, 4 Nw Stonebrook Dr, Lawton, OK 73505-9599 Ph: (719) 205-0017 | Mark Sistoso, 4301 Wilson St, Fort Sill, OK 73503-4472 Ph: (719) 205-0017 |
News Archive
When medically complex children are hospitalized, linking hospitalists to their regular outpatient providers through an inpatient consultation service were more likely to improve outcomes, according to researchers at The University of Texas Health Science Center at Houston (UTHealth).
Autism Speaks and Autism Speaks Canada who together form North America's largest autism science and advocacy organization, is pleased to announce the expansion of its Autism Treatment Network to include 17 leading children's hospitals and academic medical centers in the Canada and the U.S.
While serious infections can be transmitted from donated organs, the risk of passing Ebola virus disease from an organ donor to a recipient is extremely small. In a new editorial published in the American Journal of Transplantation, experts explain how simple assessments of donors can help ensure that the organ supply is safe, while having little impact on the donor pool.
Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced the U.S. Food and Drug Administration (FDA) has accepted Labopharm's response regarding its novel formulation of the antidepressant trazodone as complete and designated it as a Class 2 resubmission. The FDA has assigned Labopharm a new Prescription Drug User Fee Act (PDUFA) action date of February 11, 2010.
› Verified 5 days ago
Albert Arredondo Jr., MSN, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4301 Mow-way Rd, Rach (attn:mcua-qc, Ms. Prescott), Fort Sill, OK 73505 Phone: 580-458-2134 Fax: 580-458-2314 |